Jasper Therapeutics, Inc. Share Price
JSPRJasper Therapeutics, Inc. Stock Performance
Open $1.68 | Prev. Close $1.75 | Circuit Range N/A |
Day Range $1.65 - $1.82 | Year Range $1.61 - $26.05 | Volume 23,879 |
Average Traded $1.75 |
Jasper Therapeutics, Inc. Share Price Chart
About Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma, as well as conditioning agents for stem cell transplant in patients with sickle cell disease, Fanconi anemia, and severe combined immunodeficiency. Jasper Therapeutics, Inc. is headquartered in Redwood City, California.
Jasper Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $1.68 | $1.78 | +0.00% |
12-Nov-25 | $1.68 | $1.78 | +5.01% |
11-Nov-25 | $1.79 | $1.70 | -4.51% |
10-Nov-25 | $1.92 | $1.77 | -1.39% |
07-Nov-25 | $1.82 | $1.80 | -1.91% |
06-Nov-25 | $1.95 | $1.83 | -4.43% |
05-Nov-25 | $1.89 | $1.92 | +5.79% |
FAQs on Jasper Therapeutics, Inc. Share Price
Can I buy Jasper Therapeutics, Inc. shares in India?
What is the share price of Jasper Therapeutics, Inc.?
What is the 5 year returns of Jasper Therapeutics, Inc.?
What are the high & low stock price of Jasper Therapeutics, Inc. today?
What is the 52-week high and low of Jasper Therapeutics, Inc. stock?